- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 118.08M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $16.88M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $18.22M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $46.44M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $48.33M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $19.95M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $19.93M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $79.8M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $82.48M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.01M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $11.88M |
| Capex | Q1 2025 · Mar 31, 2024 | $161K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$7.89M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $52.87M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $33.37M |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.24 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $5M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$18.61M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$12.92M |